Recent Breakthrough in Sepsis Pathogen ID: Same-Day Results with T2Direct Diagnostics Enables Faster Targeted Therapy in Educational Webinar
T2 Biosystems, Inc. (TTOO)
Last t2 biosystems, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.t2biosystems.com/phoenix.zhtml?c=253528&p=irol-faq
Company Research
Source: PR Web
YORBA LINDA, Calif. (PRWEB) June 06, 2018 Sepsis is one of the top challenges facing hospitals in terms of high mortality rates, poor clinical outcomes and high cost of care. One of the major hurdles to effective sepsis management is the limitations of conventional diagnostics, which rely on blood culture and take 1 to 5 or more days to identify sepsis-causing pathogens. To advance sepsis care, hospitals are turning to T2MR®, a proven technology that does not rely on blood culture for results and has exquisite accuracy. This year, multiple new peer-reviewed studies have been published on the T2Candida® Panel and the recently FDA-cleared T2Bacteria® Panel, which provide sepsis pathogen ID results in 3 to 5 hours without the wait for blood culture, and potentially allowing for treatment on Day 0. Due to improved detection, these studies from the U.S. and EU demonstrate that clinicians are achieving faster-targeted therapy, better outcomes, enhanced stewardship, and reduced cost of car
Show less
Read more
Impact Snapshot
Event Time:
TTOO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTOO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTOO alerts
High impacting T2 Biosystems, Inc. news events
Weekly update
A roundup of the hottest topics
TTOO
News
- T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseGlobeNewswire
- T2 Biosystems Announces First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces Commercial Expansion Through Middle East DistributorGlobeNewswire
TTOO
Analyst Actions
- 4/29/24 - Canaccord Genuity
TTOO
Sec Filings
- 5/8/24 - Form FWP
- 5/7/24 - Form SC
- 5/7/24 - Form 4
- TTOO's page on the SEC website